Strs Ohio Grows Stock Holdings in Option Care Health, Inc. $OPCH

Strs Ohio boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 145.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,200 shares of the company’s stock after acquiring an additional 28,600 shares during the period. Strs Ohio’s holdings in Option Care Health were worth $1,338,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. USA Financial Formulas acquired a new position in shares of Option Care Health in the second quarter valued at approximately $26,000. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the second quarter worth $37,000. Elevation Point Wealth Partners LLC purchased a new position in Option Care Health in the 2nd quarter valued at $40,000. EverSource Wealth Advisors LLC grew its position in Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the last quarter. Finally, Future Financial Wealth Managment LLC acquired a new position in Option Care Health in the 3rd quarter valued at $56,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Trading Down 2.4%

Shares of Option Care Health stock opened at $35.33 on Wednesday. Option Care Health, Inc. has a 12-month low of $24.24 and a 12-month high of $36.80. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The stock has a market cap of $5.61 billion, a PE ratio of 28.04, a price-to-earnings-growth ratio of 2.16 and a beta of 0.80. The company has a 50-day moving average of $32.56 and a two-hundred day moving average of $29.78.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Barrington Research raised their target price on shares of Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. Wall Street Zen raised Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. Stephens upgraded Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average price target of $37.46.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the purchase, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This represents a 10.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.